Autosomal dominant hyper-IgE syndrome due to STAT3 deficiency Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

1 event

Apr 2026Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

National Institute of Allergy and Infectious Diseases (NIAID) — PHASE1

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Autosomal dominant hyper-IgE syndrome due to STAT3 deficiency.
Check the disease page for updates →

Clinical Trial Landscape

1 active trial

1Phase 1

1Total recruiting

Search clinical trials for Autosomal dominant hyper-IgE syndrome due to STAT3 deficiency →

Recent News & Research

No recent news articles indexed yet for Autosomal dominant hyper-IgE syndrome due to STAT3 deficiency.
Search PubMed for Autosomal dominant hyper-IgE syndrome due to STAT3 deficiency →

Browse all Autosomal dominant hyper-IgE syndrome due to STAT3 deficiency news →

Specialist Network

No specialists currently listed for Autosomal dominant hyper-IgE syndrome due to STAT3 deficiency.

View all Autosomal dominant hyper-IgE syndrome due to STAT3 deficiency specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰